Intracerebral Haemorrhage: Current Approaches to Acute Management
Lancet 392:1257-1268, Cordonnier, C.,et al, 2018
Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005
Can a Subset of Intracerebral Hemorrhage Patients Benefit from Hemostatic Therapy with Recombinant Activated Factor VII?
Stroke 40:833-840, Mayer,S.A.,et al, 2009
Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke 39:850-856, Diringer,M.N.,et al, 2008
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 358:2127-2137,2174, Mayer,S.A.,et al, 2008
Hemostatic Drug Therapies for Acute, Nontraumatic Intracerebral Hemorrhage
Stroke 38:204-205, Al-Shahi,R. &You,H., 2007
Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
JAMA 295:293-298, OConnell,K.A.,et al, 2006
Unexpected Posthemorrhagic Hydrocephalus in Patients Treated with rFVIIa
Neurol 67:1096, Subramaniam,S.,et al, 2006
Myocardial Injury in patients with Intracerebral Hemorrhage Treated with Recombinant Factor VIIa
Neurol 67:1053-1055, Sugg,R.M.,et al, 2006
Cost-Effectiveness of Recombinant Activated Factor VII in the Treatment of Intracerebral Hemorrhage
Stroke 37:2751-2758, Earnshaw,S.R.,et al, 2006
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005
Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage, The Recombinant Factor VIIa Experience
Stroke 36:2321-2322, Kase,C.S., 2005
Potential Applicability of Recombinant Factor VIIa for Intracerebral Hemorrhage
Stroke 36:2660-2664, Flaherty,M.L.,et al, 2005
Treatment and Prevention of Primary Intracerebral Hemorrhage
Semin Neurol 25:445-452, Towfighi,A.,et al, 2005